The portfolio delivered a 1.90% net return in Q3 2025, driven by duration positioning and investment-grade corporate bonds.
The Portfolio returned 7.33% gross, significantly outperforming the MSCI World Health Care Index's 3.12% return. Click here ...
The fund outperformed its benchmark with a 1.66% return for the quarter ending September 30, 2025. Click here for more on ...
Blue Bird (BLBD) is rated Buy amid strong revenue growth, EV momentum, and market tailwinds. Read here for a detailed ...
KB Home faces weakening demand, margin compression, discounting of high-cost inventory, and worsening guidance after Q4 2025.
The Fund performed in-line with its benchmark as municipals outperformed Treasuries amid a Federal Reserve rate cut. Read the ...
The PGIM Short Duration Muni Fund returned 2.22% in Q3, outperforming its benchmark through strong security selection in ...
PIMCO Dynamic Income Fund's $7.3B portfolio emphasizes high-yield credit and mortgages. See if PDI CEF is right for your ...
The fund delivered positive absolute returns but trailed its benchmark due to an underweight in U.S. large-cap stocks. Read ...
General Mills (GIS) is a compelling buy now, with solid dividends, resilient fundamentals, and growth in pet food. Read here ...
Intermediate-term bonds can provide steadier income than cash-like instruments while avoiding the sharp drawdowns that can ...
After a prolonged shutdown, the BLS released delayed labour and inflation data based on questionable assumptions that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results